Jones Financial Companies Lllp Has $3.65 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

Jones Financial Companies Lllp grew its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 20.8% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 40,097 shares of the company's stock after acquiring an additional 6,912 shares during the period. Jones Financial Companies Lllp's holdings in Colgate-Palmolive were worth $3,645,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the stock. FMR LLC lifted its stake in shares of Colgate-Palmolive by 65.6% in the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company's stock valued at $700,642,000 after purchasing an additional 2,674,807 shares during the last quarter. Barclays PLC lifted its stake in shares of Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after purchasing an additional 2,132,747 shares during the last quarter. State Street Corp lifted its stake in shares of Colgate-Palmolive by 3.8% in the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company's stock valued at $5,028,170,000 after purchasing an additional 1,784,411 shares during the last quarter. Nordea Investment Management AB lifted its position in Colgate-Palmolive by 32.5% during the 4th quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company's stock worth $462,121,000 after acquiring an additional 1,247,731 shares during the last quarter. Finally, AustralianSuper Pty Ltd lifted its position in Colgate-Palmolive by 941.9% during the 4th quarter. AustralianSuper Pty Ltd now owns 1,138,655 shares of the company's stock worth $103,515,000 after acquiring an additional 1,029,364 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. Royal Bank of Canada reissued a "sector perform" rating and set a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Morgan Stanley cut their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating for the company in a research report on Monday, February 3rd. JPMorgan Chase & Co. dropped their price objective on shares of Colgate-Palmolive from $103.00 to $97.00 and set an "overweight" rating on the stock in a report on Monday, February 3rd. Barclays dropped their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating on the stock in a report on Friday, January 17th. Finally, Piper Sandler dropped their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating on the stock in a report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, Colgate-Palmolive presently has an average rating of "Moderate Buy" and an average target price of $101.61.

Colgate-Palmolive Trading Up 0.9 %

NYSE CL traded up $0.81 during trading hours on Wednesday, hitting $91.87. The company's stock had a trading volume of 3,446,465 shares, compared to its average volume of 4,103,554. The stock has a fifty day moving average of $88.72 and a 200 day moving average of $95.27. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The firm has a market capitalization of $74.56 billion, a P/E ratio of 26.10, a PEG ratio of 4.20 and a beta of 0.44. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period last year, the company earned $0.87 EPS. Equities research analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were issued a $0.50 dividend. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.18%. Colgate-Palmolive's dividend payout ratio is currently 56.82%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.